These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 24287929)

  • 21. Enhanced inflammatory cytokine production at ischemia/reperfusion in human liver resection.
    Kim YI; Song KE; Ryeon HK; Hwang YJ; Yun YK; Lee JW; Chun BY
    Hepatogastroenterology; 2002; 49(46):1077-82. PubMed ID: 12143206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum antithrombin III level is well correlated with multiple indicators for assessment of liver function and diagnostic accuracy for predicting postoperative liver failure in hepatocellular carcinoma patients.
    Mizuguchi T; Kawamoto M; Meguro M; Son S; Nakamura Y; Harada K; Shibata T; Ota S; Hirata K
    Hepatogastroenterology; 2012; 59(114):551-7. PubMed ID: 22353523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis.
    Xu J; Wu C; Che X; Wang L; Yu D; Zhang T; Huang L; Li H; Tan W; Wang C; Lin D
    Mol Carcinog; 2011 Feb; 50(2):136-42. PubMed ID: 21229610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic Value of Peripheral Blood miR-148a-3p in Patients with Liver Injury After Hepatectomy Under General Anesthesia with Propofol.
    Chen Y; Duan J
    Clin Lab; 2020 Mar; 66(3):. PubMed ID: 32162885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative study assessing a new tool for occluding parenchymal blood flow during liver resection for hepatocellular carcinoma.
    Zhou S; Xue XJ; Li RR; Chen DF; Chen WY; Liu GX; Ke EM; Zheng SY
    S Afr J Surg; 2013 Feb; 51(1):12-5. PubMed ID: 23472646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Impact of surgical operation-related factors on long-term survival of patients with hepatocellular carcinoma after hepatectomy].
    Lü WP; Dong JH; Zhang WZ; Huang XQ; Wang SG; Bie P
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):386-92. PubMed ID: 18795607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minor versus major hepatic resection for small hepatocellular carcinoma (HCC) in cirrhotic patients: a 20-year experience.
    Dahiya D; Wu TJ; Lee CF; Chan KM; Lee WC; Chen MF
    Surgery; 2010 May; 147(5):676-85. PubMed ID: 20004441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Partial hepatectomy on cirrhotic liver with a right lateral tumor.
    Lee CS; Chao CC; Lin TY
    Surgery; 1985 Nov; 98(5):942-8. PubMed ID: 2997944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-22 expression in hepatocellular carcinoma and its correlation with ezrin protein.
    Zhou L; He J; Zhang Y
    J Int Med Res; 2013 Aug; 41(4):1009-16. PubMed ID: 23766411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of continuous interleukin-2 administration via the portal vein on liver regeneration following partial hepatectomy in rats.
    Wadamori K; Oka M; Tokuda N; Fujikura Y; Hazama S; Fukumoto T; Suzuki T
    Hepatology; 1996 Jun; 23(6):1578-83. PubMed ID: 8675180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative peripheral blood human telomerase reverse transcriptase mRNA concentration is not a prognostic factor for resection of hepatocellular carcinoma.
    Kim YD; Hwang S; Lee YJ; Kim KH; Ahn CS; Park KM; Moon DB; Ha TY; Song GW; Jung DH; Park SR; Hong HN; Lee SG
    Hepatogastroenterology; 2012; 59(117):1512-5. PubMed ID: 22683968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of major hepatectomy for large hepatocellular carcinoma.
    Miyoshi A; Takahashi T; Otsuka T; Kohya N; Miyazaki K
    Hepatogastroenterology; 2009; 56(91-92):768-72. PubMed ID: 19621699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma.
    Zhang Y; Takahashi S; Tasaka A; Yoshima T; Ochi H; Chayama K
    J Gastroenterol Hepatol; 2013 Mar; 28(3):565-75. PubMed ID: 22989374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome after partial hepatectomy for hepatocellular cancer within the Milan criteria.
    Fan ST; Poon RT; Yeung C; Lam CM; Lo CM; Yuen WK; Ng KK; Liu CL; Chan SC
    Br J Surg; 2011 Sep; 98(9):1292-300. PubMed ID: 21656513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients.
    Giannini EG; Savarino V; Farinati F; Ciccarese F; Rapaccini G; Marco MD; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
    Liver Int; 2013 Nov; 33(10):1594-600. PubMed ID: 23654354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum interleukin-6 and hepatocyte growth factor levels in patients after hepatectomy.
    Chijiiwa K; Saiki S; Tanaka M
    Hepatogastroenterology; 2002; 49(44):467-71. PubMed ID: 11995475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased expression of inhibitor of growth 4 correlated with poor prognosis of hepatocellular carcinoma.
    Fang F; Luo LB; Tao YM; Wu F; Yang LY
    Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):409-16. PubMed ID: 19208663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma.
    Yamamoto Y; Kosaka N; Tanaka M; Koizumi F; Kanai Y; Mizutani T; Murakami Y; Kuroda M; Miyajima A; Kato T; Ochiya T
    Biomarkers; 2009 Nov; 14(7):529-38. PubMed ID: 19863192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hematogenous dissemination of hepatocytes and tumor cells after surgical resection of hepatocellular carcinoma: a quantitative analysis.
    Wong IH; Lau WY; Leung T; Yeo W; Johnson PJ
    Clin Cancer Res; 1999 Dec; 5(12):4021-7. PubMed ID: 10632334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for major morbidity after liver resection for hepatocellular carcinoma.
    Sadamori H; Yagi T; Shinoura S; Umeda Y; Yoshida R; Satoh D; Nobuoka D; Utsumi M; Fujiwara T
    Br J Surg; 2013 Jan; 100(1):122-9. PubMed ID: 23175234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.